Shares listed in Denmark finished higher on Thursday, with the OMX Copenhagen 20 index climbing 0.46% to register a new one-month high at the close of trade in Copenhagen. Sector-level strength in Consumer Goods, Personal & Household Goods and Software & Computer Services helped push the market upward.
The session's leading individual riser on the OMX Copenhagen 20 was Zealand Pharma A/S (CSE:ZELA), which advanced 5.04% - an increase of 15.10 points - to close at 315.00. Pandora A/S (CSE:PNDORA) also posted notable gains, adding 3.38% or 16.80 points to finish at 514.20. Novo Nordisk A/S Class B (CSE:NOVOb) rose 2.12%, up 5.40 points to settle at 257.20 in late trade.
At the other end of the index, Oersted AS (CSE:ORSTED) recorded the steepest decline, slipping 2.78% or 4.55 points to end at 159.00. Biotech group Genmab (CSE:GMAB) fell 2.66%, a drop of 49.00 points, to close at 1,790.00. Wind turbine manufacturer Vestas Wind Systems A/S (CSE:VWS) was down 2.26%, or 4.60 points, finishing the session at 196.60.
Market breadth was narrowly positive on the Copenhagen exchange, with 57 stocks advancing, 55 declining and 26 finishing unchanged.
Commodities markets provided a notable backdrop to the equity moves. Crude oil for May delivery was up 2.86% - rising by 2.61 to $93.90 a barrel. Brent oil for June delivery climbed 3.73% or 3.54 to $98.47 a barrel. Gold futures for June were essentially flat, registering a negligible change of 0.00% or 0.04 to trade at $4,823.56 a troy ounce.
In foreign exchange trading, USD/DKK was up 0.21% to 6.35, while EUR/DKK was effectively unchanged, moving 0.02% to 7.47. The US Dollar Index Futures advanced 0.21% to 98.06 as of the close.
Investors assessing Danish equity performance on Thursday had to weigh concentrated gains among several consumer and software names against declines in energy-related and biotechnology stocks, while commodity and currency moves added context to market dynamics.